Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Application deadline: April 5, 2017
The Institute of Biomaterials & Biomedical Engineering in the University of Toronto invites applications for full-time tenure-stream appointment in the research areas of immunobioengineering and immunology related to stem cell biology, regenerative medicine, heart disease, and cell and organ transplantation. Novel approaches to engineer immune responses for regenerative medicine applications are of particular interest. The appointment will be at the rank of Associate or Full Professor. The expected start date is July 1, 2017.
Candidates are expected to demonstrate outstanding research, excellence in teaching and experience teaching both undergraduate and graduate courses in any of the subjects noted above. Candidates will be closely associated with Ted Rogers Centre for Heart Research (TRCHR) (see below) and / or the Canada First Research Excellence Fund (CFREF) Medicine by Design Program, and considered for appointment in appropriate partner departments at UofT, which may include Immunology, Laboratory Medicine and Pathobiology, Cell and Systems Biology, and others within the Faculties of Applied Science and Engineering, Medicine, Arts and Science, and the Toronto Academic Health Sciences Network. Applicants must have a Ph.D. degree in a relevant area. The ideal candidate will have an established reputation with internationally recognized scholarship and a demonstrated excellence in research and teaching. Excellence in research will be demonstrated by publications in top ranked and field relevant academic journals, presentations at significant conferences, awards and accolades, output of research or a research pipeline that is at high international levels and strong endorsements by referees of the highest international stature. The successful candidate will be expected to initiate and lead an innovative, independent research program of the highest international calibre. Evidence for excellence in teaching will be provided through positive teaching accomplishments and accolades, strong letters of reference, and a reflective teaching statement. Eligibility to register as a Professional Engineer in Ontario is strongly desirable. The Ted Rogers Centre for Heart Research is a unique research institute focused on heart failure across the lifespan that was enabled by a magnificent gift of $129.5 million from The Rogers Foundation, and matching contributions from the three founding partners, Hospital for Sick Children, University Health Network, and UofT. Outstanding candidates with demonstrated excellence in immunobioengineering and/or immunology research relevant to heart failure will be considered for the Loretta Rogers Chair in Immunobioengineering within the TRCHR Translational Biology and Engineering Program. Particular research areas of interest are immune modulation or tolerance induction strategies for cardiac regeneration, including immune-modifying biomaterials and human pluripotent stem cells and immune modulation in cardiac cell and tissue transplantation, but all research interests aimed at solving unaddressed immunology-related problems in heart disease and regenerative cardiac therapy will be considered. A strong track record of collaborative science, program building, productivity, excellence and leadership is essential. Through research and scholarly activities, the Chair holder will position the TRCHR as a global leader in knowledge and technology generation and translation in the area of immunobioengineering related to heart disease. The Chair is one of eight being created in TRCHR, and is enabled by a fund of $4.8M consisting of a $3M endowment and $1.8M expendable funds. The term of the Chair is five years, with opportunity for renewal. Applicants may also be interested in the Medicine by Design Senior Chair in Immunobioengineering position also listed on the UofT Careers page. Salary and rank will be commensurate with qualifications and experience. All application documents must be received online by 11:59PM on April 5, 2017. All qualified candidates are invited to apply by clicking on the link below. Applications must include a C.V. with a list of publications, research statement, teaching statement and cover sheet. Candidates must arrange to have three letters of reference (on letterhead, signed, and scanned) sent directly by referees to Professor Christopher Yip via email at firstname.lastname@example.org. For further information about the application process, please see the submission guidelines.
The University of Toronto is strongly committed to diversity within its community and especially welcomes applications from racialized persons / persons of colour, women, Indigenous / Aboriginal People of North America, persons with disabilities, LGBTQ persons, and others who may contribute to the further diversification of ideas.
As part of your application, you will be asked to complete a brief Diversity Survey. This survey is voluntary. Any information directly related to you is confidential and cannot be accessed by search committees or human resources staff. Results will be aggregated for institutional planning purposes. For more information, please see http://uoft.me/UP.
All qualified candidates are encouraged to apply; however, Canadians and permanent residents will be given priority.
© 2017 European Society of Cardiology. All rights reserved